1. Academic Validation
  2. Expression, purification, characterization of human 3-methylcrotonyl-CoA carboxylase (MCCC)

Expression, purification, characterization of human 3-methylcrotonyl-CoA carboxylase (MCCC)

  • Protein Expr Purif. 2007 Jun;53(2):421-7. doi: 10.1016/j.pep.2007.01.012.
Ching-Hsuen Chu 1 Dong Cheng
Affiliations

Affiliation

  • 1 Department of Obesity and Metabolic Research, Pharmaceutical Research Institute, Bristol-Myers Squibb Company, P.O. Box 5400, Princeton, NJ 08543-5400, USA.
Abstract

The current study reports the use of baculovirus system to express functionally active human recombinant 3-methylcrotonyl-CoA carboxylase (MCCC), a heteromultimeric complex that is composed of alpha and beta subunits which are encoded by distinct genes. Using immuno-affinity purification, an efficient protocol has been developed to purify the active MCCC which appears to reside in a approximately 500-800kDa complex in Superpose-6 gel-filtration chromatography. Consistent with the native Enzyme, in the recombinant human MCCC, the stoichiometry of alpha and beta subunits are at a one:one ratio. The k(cat) value of the recombinant Enzyme is determined to be approximately 4.0s(-1). It also possesses K(m) values (ATP: 45+/-11microM; 3-methylcrotonyl-CoA: 74+/-7microM) similar to those reported for the native Enzyme. The recombinant human MCCC described here may provide a counter-screen Enzyme source for testing cross reactivity for inhibitors against acetyl-CoA carboxylases which are designed to treat obesity, type 2 diabetes and other metabolic disorders.

Figures